Vimarsana
Biggest News Aggregation in the World

Page 10 - Brain Plasticity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brain Plasticity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brain Plasticity Today - Breaking & Trending Today

13 July, 2022 – Episode 883 – JWSTOMG! - Vimarsana News

13 July, 2022 – Episode 883 – JWSTOMG!

Did you see the images from JWST telescope? Well, we did and you can hear all about it on this week's episode of This Week In Science!

Source: twis.org
How mindfulness and dance can stimulate a part of the brain that can improve mental health - Vimarsana News

How mindfulness and dance can stimulate a part of the brain that can improve mental health

The brain’s somatosensory cortex may help enrich our emotional experiences and improve our mental health. Mindfulness and dance movement therapy may be effective ways to activate it.

Exercise Of Varying Intensities May Influence Brain Function Differently: Study - Vimarsana News

Exercise Of Varying Intensities May Influence Brain Function Differently: Study

Researchers have shown that low and high exercise intensities influence brain function differently, a finding that may pave the way for better clinical applications of physical activity in patients recovering from mental illness or brain injury.

5 years after the Quebec City mosque shooting: How do children and teens cope with the trauma? - Vimarsana News

5 years after the Quebec City mosque shooting: How do children and teens cope with the trauma?

How can scientific literature on interpersonal trauma help us better understand the impact of tragedy, especially on children who are still developing?

NervGen Pharma Corp.: NervGen Pharma Applauds President Biden Signing Defense Bill - Vimarsana News

NervGen Pharma Corp.: NervGen Pharma Applauds President Biden Signing Defense Bill

Department of Defense now able to Move Forward on Brain Plasticity Research Cincinnati, Ohio--(Newsfile Corp. - January 4, 2022) - NervGen Pharma Corp., (TSXV: NGEN) (OTCQX: NGENF) through its subsidiary